PTEN in hereditary and sporadic cancer
Germline pathogenic phosphatase and tensin homolog (PTEN) mutations cause PTEN hamartoma tumor syndrome (PHTS), characterized by various benign and malignant tumors of the thyroid, breast, endometrium, and other organs. Patients with PHTS may present with other clinical features such as macrocephaly...
Main Authors: | Ngeow, Joanne, Eng, Charis |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/148895 |
Similar Items
-
Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention
by: Maria Teresa Vietri, et al.
Published: (2021-04-01) -
Distinguishing between PTEN clinical phenotypes through mutation analysis
by: Stephanie Portelli, et al.
Published: (2021-01-01) -
Phenotype-genotype correlation in β-thalassemia
by: R. Galanello, et al.
Published: (2011-12-01) -
65 years of the double helix : the advancements of gene editing and potential application to hereditary cancer
by: Tan, Zi Ying, et al.
Published: (2020) -
Genotypic–Phenotypic Correlations of Hereditary Hyperferritinemia-Cataract Syndrome: Case Series of Three Brazilian Families
by: Olivia A. Zin, et al.
Published: (2023-07-01)